Therefore, in patients with Lynch syndrome, colonoscopy surveillance should begin at the age of 20–25 years for those with MLH1 or MSH2 as the causative gene and at 30–35 years for their counterparts with MSH6 or PMS2 as the causative gene when the onset of CRC is late. This evidence concerns the gene MLH1 and colorectal carcinoma.